182 related articles for article (PubMed ID: 35893151)
21. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China.
Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC
Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420
[TBL] [Abstract][Full Text] [Related]
22. Cis-2-dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-resistant Candida albicans.
Yang DL; Hu YL; Yin ZX; Zeng GS; Li D; Zhang YQ; Xu ZH; Guan XM; Weng LX; Wang LH
Biomed Environ Sci; 2019 Mar; 32(3):199-209. PubMed ID: 30987694
[TBL] [Abstract][Full Text] [Related]
23. Azole resistance in Candida albicans from animals: Highlights on efflux pump activity and gene overexpression.
Rocha MFG; Bandeira SP; de Alencar LP; Melo LM; Sales JA; Paiva MAN; Teixeira CEC; Castelo-Branco DSCM; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Brilhante RSN
Mycoses; 2017 Jul; 60(7):462-468. PubMed ID: 28295690
[TBL] [Abstract][Full Text] [Related]
24. Resensitization of Fluconazole-Resistant Urinary
Edward EA; Mohamed NM; Zakaria AS
Pol J Microbiol; 2020 Sep; 69(1):73-84. PubMed ID: 32189482
[TBL] [Abstract][Full Text] [Related]
25. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
26. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
[TBL] [Abstract][Full Text] [Related]
27. Effect of biogenic selenium nanoparticles on ERG11 and CDR1 gene expression in both fluconazole-resistant and -susceptible
Parsameher N; Rezaei S; Khodavasiy S; Salari S; Hadizade S; Kord M; Ayatollahi Mousavi SA
Curr Med Mycol; 2017 Sep; 3(3):16-20. PubMed ID: 29707669
[TBL] [Abstract][Full Text] [Related]
28. Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses.
Chow NA; Muñoz JF; Gade L; Berkow EL; Li X; Welsh RM; Forsberg K; Lockhart SR; Adam R; Alanio A; Alastruey-Izquierdo A; Althawadi S; Araúz AB; Ben-Ami R; Bharat A; Calvo B; Desnos-Ollivier M; Escandón P; Gardam D; Gunturu R; Heath CH; Kurzai O; Martin R; Litvintseva AP; Cuomo CA
mBio; 2020 Apr; 11(2):. PubMed ID: 32345637
[No Abstract] [Full Text] [Related]
29. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ
Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
[TBL] [Abstract][Full Text] [Related]
30. Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical
El-Ganiny AM; Kamel HA; Yossef NE; Mansour B; El-Baz AM
Saudi Pharm J; 2022 Mar; 30(3):245-255. PubMed ID: 35498219
[No Abstract] [Full Text] [Related]
31. Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole.
Ahmad A; Khan A; Manzoor N
Eur J Pharm Sci; 2013 Jan; 48(1-2):80-6. PubMed ID: 23111348
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
33. [Molecular mechanisms of fluconazole resistance in clinical isolates of Candida glabrata].
Shen YZ; Lu HZ; Zhang YX
Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):245-9. PubMed ID: 20450660
[TBL] [Abstract][Full Text] [Related]
34. Rapid Detection of
Hou X; Lee A; Jiménez-Ortigosa C; Kordalewska M; Perlin DS; Zhao Y
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397051
[No Abstract] [Full Text] [Related]
35. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
36. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
37. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
[TBL] [Abstract][Full Text] [Related]
38.
Maphanga TG; Naicker SD; Kwenda S; Muñoz JF; van Schalkwyk E; Wadula J; Nana T; Ismail A; Coetzee J; Govind C; Mtshali PS; Mpembe RS; Govender NP;
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0051721. PubMed ID: 34228535
[TBL] [Abstract][Full Text] [Related]
39. Molecular Characterization of
Reslan L; Araj GF; Finianos M; El Asmar R; Hrabak J; Dbaibo G; Bitar I
Front Microbiol; 2021; 12():770635. PubMed ID: 35145489
[TBL] [Abstract][Full Text] [Related]
40. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
